[3O17a] Drug, Drug discovery

[3O17a-04] High NAD⁺ levels caused by activation of NAD⁺ synthesis pathway induce resistance to PARP inhibitors in BRCA1 knockout pancreatic cancer cells.

^○Yuka Sasaki^1,2, Ryusuke Nakatsuka¹, Amane Inoue¹, Mitsuko Masutani², Tadashige Nozaki¹ (1.Osaka Dental Univ., 2.Nagasaki Univ.)

Login required to view

Login is required to view some content.

Log in